August 2012—After years of seeing value destroyed by R&D excesses, biopharmaceutical companies can gain healthier returns—but only if they recognize several new imperatives.more
April 2013—Pharmaceutical R&D suffers from declining success rates and a stagnant pipeline. Big data and the analytics that go with it could be a key element of the cure.more
December 2011—Lower profit margins suggest a need for new business models.more
August 2012—The sector can restore lost value by focusing intently on manufacturing innovation.more
February 2012—The country may well foster new models of innovation, but success will require a long-term commitment and talent development.more
February 2010—Gone is the time when R&D in developed markets could meet the pharmaceutical needs of emerging ones. A local presence is required.more
February 2010—Scientific innovation is not the only route to higher R&D productivity. Attention to the familiar management areas of cost, speed, and decision making can still reap rewards.more
April 2009—By matching the productivity of top drugmakers, average ones could enjoy labor and unit-cost savings worth five to six percentage points of earnings before interest and taxes.more
April 2012—Global pharma companies are missing a chance to serve Brazil’s increasingly prosperous and growing middle class.more
July 2009—The CEO and chairman of Novartis AG shares his personal approach to management and leadership and discusses health care reform, the economic downturn, and executive compensation.more
February 2010—Personalized medicine promises to increase the quality of clinical care and, in some cases, to decrease health care costs. The biggest hurdles are economic, not scientific.more
January 2010—Payors can help improve consumers’ health and reduce costs by providing information, choice, and incentives that encourage healthier lifestyles and value-conscious consumption of health care. more
May 2010—The development of an automated payment network would reduce bad debt, cut administrative costs, and save billions of dollars.more
May 2010—Innovators—some from developing nations—have found ways to deliver care effectively at significantly lower cost while increasing access and quality.more
The material on this page draws on the research and experience of McKinsey consultants and other sources. To learn more about our expertise, please visit the Healthcare Systems & Services Practice, Operations Practice, Pharmaceuticals & Medical Products Practice.